Monday, February 8, 2016

Richter's Transformation and on the Road Again

Friends,

This week in the Beyond the Basics section of the CLL Society website, we have posted an interview from ASH 2015 with Dr. Januario Castro, although discussing an abstract that was presented at the 2015 iwCLL meeting. We talked about Richter’s Transformation, one of the most aggressive turns that chronic lymphocytic leukemia (CLL) can take and specifically, a clinical trial that will be available soon that uses a non-chemo approach to therapy. You can see that interview here. [http://cllsociety.org/2016/02/richters-transformation-of-cll/]

CLL Meeting in Tampa, FL: For those of you in the Tampa area, there is a CLL patient meeting hosted by the Florida Society of Clinical Oncology (FLASCO) being held on February 11th at the Embassy Suites Tampa Airport at 5:00 PM. A complimentary buffet dinner will be provided. I’ll be there giving a talk about the importance of support groups. Also, you’ll have the opportunity to ask questions of the expert speakers. Register and find out more information here. [https://www.flasco.org/events/living-with-cll-tampa/]

CLL Meeting in Miami, FL: For those of you in the Miami area, there is a CLL patient meeting hosted by the Florida Society of Clinical Oncology (FLASCO) being held on February 24th at the Miami Marriott Dadeland at 5:00 PM. A complimentary buffet dinner will be provided. I’m not able to attend this meeting, but you’ll have the opportunity to ask questions of the expert speakers. Register and find out more information here. [https://www.flasco.org/events/living-with-cll-miami/]

CLL Meeting in Atlanta, GA: For those of you in the Atlanta area, we just became aware of another patient meeting in February: Saturday, February 27th in Atlanta starting at 9:30 AM at the Sheraton Suites Galleria-Atlanta. CLL patients will be sharing their personal stories, and a local CLL expert will be providing a talk on the basics of CLL. You can call 844-482-6815 to register. A complimentary meal and parking will be provided and you are welcome to bring a guest. I will be at the meeting with an exhibit table and will stay afterwards to meet with attendees to discuss the resources available from the CLL Society. I look forward to meeting you there.

Stay strong.

We are all in this together.

Brian Koffman, MD
Volunteer Medical Director of the CLL Society


Labels: , , ,

1 Comments:

Blogger Facu Stingo said...

Dear Dr. Brian Koffman, I do believe this paper is very interesting but I also believe that a cohort of 2 patients is very small (don't mean to criticize their extremely great job). Researching for more information I founded another paper where 52 CLL patients were treated with Metylprednisone, Lanidomide and Ofatumumab. The responses were variable depending on patients status (TN or R/R).
There is another clinical trial phase ½ that I find really interesting of the combination of Venetoclax, Ibrutinib and Obitubuzumab. You can find both links at the end of my comment.
If find all this information extremely encouraging and I agree with you fully, I can also smell a cure. Wishing you the best with your medical exams and I’m glad your LFTs are back to normal.
Best regards
Dr. Facundo Stingo
https://ash.confex.com/ash/2015/webprogram/Paper86560.html
https://clinicaltrials.gov/ct2/show/NCT02427451?term=abt+199+ibrutinib&rank=3

February 13, 2016 at 3:37 PM  

Post a Comment

Subscribe to Post Comments [Atom]

<< Home